» Articles » PMID: 28830106

Digital Pharmacovigilance and Disease Surveillance: Combining Traditional and Big-Data Systems for Better Public Health

Overview
Journal J Infect Dis
Date 2017 Aug 24
PMID 28830106
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The digital revolution has contributed to very large data sets (ie, big data) relevant for public health. The two major data sources are electronic health records from traditional health systems and patient-generated data. As the two data sources have complementary strengths-high veracity in the data from traditional sources and high velocity and variety in patient-generated data-they can be combined to build more-robust public health systems. However, they also have unique challenges. Patient-generated data in particular are often completely unstructured and highly context dependent, posing essentially a machine-learning challenge. Some recent examples from infectious disease surveillance and adverse drug event monitoring demonstrate that the technical challenges can be solved. Despite these advances, the problem of verification remains, and unless traditional and digital epidemiologic approaches are combined, these data sources will be constrained by their intrinsic limits.

Citing Articles

Infodemiology and Infoveillance of the Four Most Widespread Arbovirus Diseases in Italy.

Santangelo O, Provenzano S, Vella C, Firenze A, Stacchini L, Cedrone F Epidemiologia (Basel). 2024; 5(3):340-352.

PMID: 39051204 PMC: 11270390. DOI: 10.3390/epidemiologia5030024.


Identification of Early Warning Signals of Infectious Diseases in Hospitals by Integrating Clinical Treatment and Disease Prevention.

Zhang L, Li M, Zhi C, Zhu M, Ma H Curr Med Sci. 2024; 44(2):273-280.

PMID: 38632143 DOI: 10.1007/s11596-024-2850-x.


Real-World Data and Evidence in Lung Cancer: A Review of Recent Developments.

Kokkotou E, Anagnostakis M, Evangelou G, Syrigos N, Gkiozos I Cancers (Basel). 2024; 16(7).

PMID: 38611092 PMC: 11010882. DOI: 10.3390/cancers16071414.


Assessing the utility of COVID-19 case reports as a leading indicator for hospitalization forecasting in the United States.

Reich N, Wang Y, Burns M, Ergas R, Cramer E, Ray E Epidemics. 2023; 45:100728.

PMID: 37976681 PMC: 10871058. DOI: 10.1016/j.epidem.2023.100728.


Effectiveness of Public Health Digital Surveillance Systems for Infectious Disease Prevention and Control at Mass Gatherings: Systematic Review.

Maddah N, Verma A, Almashmoum M, Ainsworth J J Med Internet Res. 2023; 25:e44649.

PMID: 37204833 PMC: 10238952. DOI: 10.2196/44649.


References
1.
Olson D, Konty K, Paladini M, Viboud C, Simonsen L . Reassessing Google Flu Trends data for detection of seasonal and pandemic influenza: a comparative epidemiological study at three geographic scales. PLoS Comput Biol. 2013; 9(10):e1003256. PMC: 3798275. DOI: 10.1371/journal.pcbi.1003256. View

2.
Signorini A, Segre A, Polgreen P . The use of Twitter to track levels of disease activity and public concern in the U.S. during the influenza A H1N1 pandemic. PLoS One. 2011; 6(5):e19467. PMC: 3087759. DOI: 10.1371/journal.pone.0019467. View

3.
Chee B, Berlin R, Schatz B . Predicting adverse drug events from personal health messages. AMIA Annu Symp Proc. 2011; 2011:217-26. PMC: 3243174. View

4.
White R, Tatonetti N, Shah N, Altman R, Horvitz E . Web-scale pharmacovigilance: listening to signals from the crowd. J Am Med Inform Assoc. 2013; 20(3):404-8. PMC: 3628066. DOI: 10.1136/amiajnl-2012-001482. View

5.
White R, Harpaz R, Shah N, DuMouchel W, Horvitz E . Toward enhanced pharmacovigilance using patient-generated data on the internet. Clin Pharmacol Ther. 2014; 96(2):239-46. PMC: 4111778. DOI: 10.1038/clpt.2014.77. View